Strategic capital from CVS, Optum, and Elevance is funding the infrastructure to make that viable
5.2.5 Future directions: targeting cell-type specific ferroptosis programs Emerging single-cell and spatial transcriptomic analyses have revealed that ferroptosis susceptibility varies significantly among different joint-resident cells in OA
Paddon-Jones D, Sheffield-Moore M, Katsanos CS, Zhang XJ, Wolfe RR
Bottom line: switching from Zepbound to Wegovy Switching from Zepbound to Wegovy is a legitimate option, but it's not a decision to take lightly
Kubota M, Kimura Y, Shimojo M, Takado Y, Duarte JM, Takuwa H et al
Development and Selectivity The development of AOD9604 was based on the observation that the C-terminal region of growth hormone possesses independent metabolic regulatory functions distinct from the growth-promoting effects mediated by the N-terminal receptor-binding domain